Ocean Power Technologies, Inc. — Form 8-K Summary
Reporting date: September 24, 2026; the filing was signed September 25, 2026. The reported transactions were entered into on September 25, 2026, creating a date inconsistency in the filing.
Business Context and Period
The filing reports a restructuring of the company’s convertible note financing and an amendment to outstanding common warrants. Management also participated in a Proactive interview furnished under Regulation FD.
Key Financial and Capital Structure Terms
- Holders exchanged the company’s Series C-1 Convertible Notes, issued April 1, 2026, for Series D Convertible Notes with an equivalent principal amount. The Existing Notes were cancelled.
- The Series D Notes have a 4.5% annual interest rate, increasing to 13% during an event of default.
- The Series D Notes mature 18 months after issuance at a premium equal to 13% of face value, unless earlier converted.
- The fixed conversion price was reduced from $12.00 to $2.45. An alternative conversion price is 93% of the lowest volume-weighted average price during the seven trading days preceding conversion.
- Amortization payments otherwise due under the notes will begin January 1, 2027.
- The exercise price of the common warrants issued June 8, 2026 was reduced from $12.00 to $2.45.
- Note conversions are subject to a 4.99% beneficial ownership cap, which may be increased or decreased by notice but may not exceed 9.99%. Any increase becomes effective after 61 days.
- Conversions are also limited to 19.99% of the common shares outstanding as of the Exchange Agreement date until required NYSE American stockholder approval is obtained.
- The filing does not provide the aggregate principal amount of the exchanged notes, the number of potentially issuable shares, or current cash, revenue, profit, cash flow, margin, debt, or liquidity figures.
Material Changes Versus the Prior Arrangements
- The Series D Notes substantially retain the terms of the Series C-1 Notes but materially reduce the fixed conversion price from $12.00 to $2.45 and add a market-price-based alternative conversion formula.
- The warrant exercise price was reduced from $12.00 to $2.45.
- Amortization payments were deferred until January 1, 2027, according to the filing.
Outlook, Commentary, Risks, and Unusual Items
- The filing provides no formal financial guidance or quantified business outlook.
- The lower conversion and warrant exercise prices may increase potential dilution to existing common stockholders.
- The alternative conversion formula could result in issuance at a discount to recent market prices, subject to the stated ownership and exchange-listing limitations.
- The 13% default interest rate and 13% maturity premium increase the company’s financing burden if applicable.
- The filing does not include the substance of management’s Proactive interview beyond identifying the participants; the transcript is furnished as Exhibit 99.1.
- The filing’s exhibit references appear inconsistent: the narrative refers to the warrant amendment as Exhibit 10.2, while the exhibit list identifies it as Exhibit 10.3 and identifies the Series D Note as Exhibit 10.2.
Important Facts for Investors to Verify
- Aggregate principal amount of the Series D Notes and the corresponding maximum potential share issuance.
- Outstanding share count and the effect of the 19.99% issuance limitation.
- Whether and when NYSE American stockholder approval will be sought or obtained.
- Expected amortization schedule beginning January 1, 2027.
- Potential dilution from both note conversions and warrant exercises at the revised $2.45 price or the alternative market-price formula.
- Complete terms in Exhibits 10.1, 10.2, and 10.3, including any omitted covenants, redemption provisions, defaults, and security interests.
- The correct transaction and filing dates and the discrepancy in the warrant amendment exhibit reference.